Effect of Silibinin(A) as a Potential Anti-obesity Agent
Condition(s):Overweight and Obesity; Hypercholesterolemia; HypertriglyceridemiaLast Updated:June 23, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Overweight and Obesity; Hypercholesterolemia; HypertriglyceridemiaLast Updated:June 23, 2023Active, not recruiting
Condition(s):Dyslipidemia; Menopause; ObesityLast Updated:February 28, 2019Terminated
Condition(s):HIV Infections; Hepatitis CLast Updated:September 15, 2011Completed
Condition(s):Ulcerative ColitisLast Updated:January 19, 2024Not yet recruiting
Condition(s):HealthyLast Updated:July 17, 2018Completed
Condition(s):Diabetic Nephropathies; Proteinuria; Oxidative StressLast Updated:June 27, 2016Completed
Condition(s):Hepatitis C, ChronicLast Updated:August 18, 2006Completed
Condition(s):Metabolic Associated Fatty Liver DiseaseLast Updated:June 22, 2023Recruiting
Condition(s):Rheumatoid Arthritis; Psoriatic Arthritis; PsoriasisLast Updated:February 26, 2024Recruiting
Condition(s):HepatitisLast Updated:April 23, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.